Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rifampicin in Multiple System Atrophy
NCT01287221Phase 3Terminated
- Start
- Mar 2011
- Primary completion
- Nov 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of rifampicin in multiple system atrophy (MSA). Started Mar 2011; status: terminated.
02
Drugs
rifampicin
03
Conditions
multiple system atrophy (MSA)
Beyond the preview
Go deeper on NCT01287221.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01287221.